Sarepta Therapeutics has shared initial clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead...
A research study led by Dr Alireza Faridar and Dr Stanley Appel at the Houston Methodist Neurological Institute has demonstrated the involvement of the peripheral immune...
Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech called Loxo Oncology, and his boss,...
The war with Iran has focused the world’s attention on nuclear weapons and oil. Those risks are real. But there is a third category of danger...
It was 2023. ChatGPT had been released less than five months earlier. Justin Norden was sitting around a table with a dozen health care leaders at...
I recently spent a long afternoon hiding from the nurse in the emergency room of a prestigious hospital. My sister and I were there with my...
Novo Nordisk and its Chinese partner have reported another midphase win for their triple G candidate, sharing diabetes data to add to the momentum generated by...
China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the oral obesity race.
WASHINGTON — Robert Malone, an outspoken medical doctor and ally of health secretary Robert F. Kennedy Jr., is stepping away from a panel of federal vaccine...
Sanofi has agreed to license from Kali Therapeutics its lead tri-specific T-cell engager (TCE) antibody candidate KT501, which is being developed to treat a variety of...
Scan to Read